Microreactors as new tools for drug discovery and development

Area of Science:

• Chemical Engineering
• Pharmaceutical Sciences
• Drug Discovery

Background:

• Traditional large-scale batch reactors limit flexibility and safety in pharmaceutical production.
• Flow microreactors offer enhanced control and safety for fine chemical synthesis.
• Pharmaceutical research and development (R&D) requires efficient methods for lead compound identification and optimization.

Purpose of the Study:

• To describe the application of microreactors in pharmaceutical R&D for accelerated drug discovery.
• To present an integrated micro-scaled chemical synthesis and bioassay system for rapid lead optimization.
• To highlight the use of microreactors for point-of-use synthesis of positron emission tomography (PET) ligands.

Main Methods:

• Utilizing microreactors to create an integrated micro-scaled chemical synthesis and bioassay system.
• Implementing fast-cycling iterative searches within diverse chemical space.
• Employing microreactors for the down-scaled and accelerated synthesis of short-lived biomarkers (PET ligands).

Main Results:

• Demonstrated enhanced and inherently safer production protocols using microreactors.
• Developed a system for rapid discovery and optimization of novel drug leads.
• Achieved significant down-scaling and acceleration in the synthesis of PET ligands.

Conclusions:

• Microreactors provide a flexible and safer alternative to batch reactors in pharmaceutical production.
• Integrated microreactor systems enhance the efficiency of drug discovery and lead optimization.
• Accelerated synthesis of PET ligands using microreactors can reduce drug approval timelines and resource requirements.